ABVC BIOPHARMA, INC. - ABVC

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$1.858M
QoQ value delta ($000)
-$523K (-21.97%)
Implied price effect (QoQ)
-29.96%
Shares
Total shares
875,006
QoQ shares delta
+89,676 (+11.42%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (ABVC)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 15 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 613 287,937 0.0%
GEODE CAPITAL MANAGEMENT, LLC 431 202,365 0.0%
RENAISSANCE TECHNOLOGIES LLC 243 114,263 0.0%
STATE STREET CORP 155 72,800 0.0%
BlackRock, Inc. 120 56,442 0.0%
CITADEL ADVISORS LLC 118 55,543 0.0%
NORTHERN TRUST CORP 68 32,087 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 42 20,100 0.0%
JANE STREET GROUP, LLC 23 10,867 0.0%
XTX Topco Ltd 23 11,261 0.0%
MORGAN STANLEY 11 5,175 0.0%
Tower Research Capital LLC (TRC) 6 3,193 0.0%
UBS Group AG 5 2,588 0.0%
BANK OF AMERICA CORP /DE/ 0 189 0.0%
SIMPLEX TRADING, LLC 0 196 0.0%